Kamlesh Prabhu

Kamlesh Prabhu is an accomplished professional in the field of pharmacovigilance and medical safety, currently serving as the Director of Medical Safety at BioNTech SE since August 2024. Previously, Kamlesh held the position of Sr. Director of Safety and Pharmacovigilance at Omega Therapeutics, overseeing clinical safety aspects and supporting clinical functions. Experience includes significant roles at SQZ Biotechnologies, where Kamlesh established safety governance infrastructure, and Shire, where responsibilities included ensuring compliance with regulatory submission timelines. Early career included positions at Sanofi focusing on pharmacovigilance metrics and global patient safety operations. Kamlesh holds a Master's degree in Regulatory Affairs from Northeastern University and a Bachelor's degree in Pharmacy from MET Institute of Pharmacy.